Acacia Subsidiary Acquires 13 Fluorescence Microscopy Patents
Acacia Research Corporation (NASDAQ: ACTG) announced today that a
subsidiary has acquired 13 US and foreign patents and applications on
“Acacia continues to increase the number of leading patent portfolios in
the medical device and life sciences space,” commented Matt Vella, CEO.
“Fluorescence microscopy is of key relevance to the life sciences
because it enables three-dimensional imaging of cellular constituents
with unrivaled specificity.”